| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.13 | 3e-05 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.16 | 7e-05 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.006 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.008 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.097 | 0.008 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.099 | 0.008 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.008 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.008 |